OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Facial Numbness, Dysarthria, Muscle Atrophy, and Weakness in a Young Patient	422
JAMA Neurology Peer Reviewers in 2020	364
Automated Imaging Differentiation for Parkinsonism	321
Error in Author Name	317
Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis	263
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	257
Diplopia and Ptosis in an Older Woman	253
Origin of Transthyretin in Cerebral Amyloid Angiopathy	247
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	229
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up	220
Early Posttraumatic Seizures—Putting Things in Perspective	204
Equipping AI for Unbiased and Inclusive Neurology	203
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	202
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis	179
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	176
Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study	176
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	173
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	170
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	169
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	164
Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus	164
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	164
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	161
JAMA Neurology	160
The Neurologist’s Imperative in Brain Death	159

Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis	154
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	153
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	150
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	147
Time to Change the Current Clinical Classification of Multiple Sclerosis?	146
Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke	143
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	143
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	135
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	130
JAMA Neurology	126
Is It Really Itching?	125
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome	124
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	121
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	117
Absent Blood Oxygen Level–Dependent Functional Magnetic Resonance Imaging Activation of the Orbitofrontal Cortex in a Patient With Persistent Cacosmia and Cacogeusia After COVID-19 Infection	115
Advanced Practice Clinicians—Neurology’s Underused Resource	114
Error in Abstract	113
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	113
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	112
Role of the X Chromosome in Alzheimer Disease Genetics	111
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	109
Visual Neglect After an Isolated Lesion of the Superior Colliculus	108
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	107
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	102
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	102
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	100
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	98
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	97
Error in Figure	96
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke	94
Error in Figure	93
Errors in Figure 2	92
Histologic Anatomy of Neurocysticercosis	91
Error in Additional Contributions	89
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	88
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	86
Sleep Recording for the Diagnosis and Treatment of Paraplegia	83
Is It Really Itching?—Reply	82
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	81
JAMA Neurology	81
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	81
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	80
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	79
Do Neurologists Need a Goldwater Rule?	78
Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures	78
Methylphenidate for Apathy in Alzheimer Disease—Why Should We Care?	77
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion	75
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum	75
JAMA Neurology	74
Acute Myelopathy in a Man With Cutaneous Papules	74

Visualization of Parkinsonian Tongue Tremor on Ultrasonography